Literature DB >> 16818864

Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.

Zindel V Segal1, Sidney Kennedy, Michael Gemar, Karyn Hood, Rebecca Pedersen, Tom Buis.   

Abstract

CONTEXT: Episode remission in unipolar major depression, while distinguished by minimal symptom burden, can also be a period of marked sensitivity to emotional stress as well as an increased risk of relapse.
OBJECTIVE: To examine whether mood-linked changes in dysfunctional thinking predict relapse in recovered patients who were depressed.
DESIGN: In phase 1 of this study, patients with major depressive disorder were randomly assigned to receive either antidepressant medication or cognitive behavior therapy. In phase 2, patients who achieved clinical remission underwent sad mood provocation and were then observed with regular clinical assessments for 18 months.
SETTING: Outpatient psychiatric clinics at the Centre for Addiction and Mental Health, Toronto, Ontario. PARTICIPANTS: A total of 301 outpatients with major depressive disorder, aged 18 to 65 years, participated in phase 1 of this study and 99 outpatients with major depressive disorder in remission, aged 18 to 65 years, participated in phase 2. MAIN OUTCOME MEASURE: Occurrence of a relapse meeting DSM-IV criteria for a major depressive episode as assessed by the longitudinal interval follow-up evaluation and a Hamilton Depression Rating Scale score of 16 or greater.
RESULTS: Patients who recovered through antidepressant medication showed greater cognitive reactivity following the mood provocation than those who received cognitive behavior therapy. Regardless of type of prior treatment, the magnitude of mood-linked cognitive reactivity was a significant predictor of relapse over the subsequent 18 months. Patients whose mood-linked endorsement of dysfunctional attitudes increased by a minimum of 8 points had a significantly shorter time to relapse than those whose scores were not as elevated.
CONCLUSIONS: The vulnerability of remitted depressed patients for illness relapse may be related to the (re)activation of depressive thinking styles triggered by temporary dysphoric states. This is the first study to link such differences to prognosis following successful treatment for depression. Further understanding of factors predisposing to relapse/recurrence in recovered patients may help to shorten the potentially lifelong course of depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818864     DOI: 10.1001/archpsyc.63.7.749

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  99 in total

1.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

2.  Neuroimaging social emotional processing in women: fMRI study of script-driven imagery.

Authors:  Paul A Frewen; David J A Dozois; Richard W J Neufeld; Maria Densmore; Todd K Stevens; Ruth A Lanius
Journal:  Soc Cogn Affect Neurosci       Date:  2010-06-04       Impact factor: 3.436

3.  Stuck in a rut: rethinking depression and its treatment.

Authors:  Paul E Holtzheimer; Helen S Mayberg
Journal:  Trends Neurosci       Date:  2010-11-08       Impact factor: 13.837

4.  Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care.

Authors:  Timothy B Baker; Richard M McFall; Varda Shoham
Journal:  Psychol Sci Public Interest       Date:  2008-11-01

5.  Detecting Sudden Gains during Treatment of Major Depressive Disorder: Cautions from a Monte Carlo Analysis.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  Curr Psychiatry Rev       Date:  2015-02-01

Review 6.  Constructive and unconstructive repetitive thought.

Authors:  Edward R Watkins
Journal:  Psychol Bull       Date:  2008-03       Impact factor: 17.737

Review 7.  Neurobiological mechanisms in major depressive disorder.

Authors:  Marije aan het Rot; Sanjay J Mathew; Dennis S Charney
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

8.  Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers.

Authors:  Jamie Horder; Philip J Cowen; Martina Di Simplicio; Michael Browning; Catherine J Harmer
Journal:  Psychopharmacology (Berl)       Date:  2009-04-01       Impact factor: 4.530

9.  Attending to the present: mindfulness meditation reveals distinct neural modes of self-reference.

Authors:  Norman A S Farb; Zindel V Segal; Helen Mayberg; Jim Bean; Deborah McKeon; Zainab Fatima; Adam K Anderson
Journal:  Soc Cogn Affect Neurosci       Date:  2007-12       Impact factor: 3.436

10.  The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis.

Authors:  Lynn Boschloo; Ella Bekhuis; Erica S Weitz; Mirjam Reijnders; Robert J DeRubeis; Sona Dimidjian; David L Dunner; Boadie W Dunlop; Ulrich Hegerl; Steven D Hollon; Robin B Jarrett; Sidney H Kennedy; Jeanne Miranda; David C Mohr; Anne D Simons; Gordon Parker; Frank Petrak; Stephan Herpertz; Lena C Quilty; A John Rush; Zindel V Segal; Jeffrey R Vittengl; Robert A Schoevers; Pim Cuijpers
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.